Global Cancer Statistics

Ca-A Cancer Journal for Clinicians

Volumn 49, Issue 1, 1999, Pages 33-64

  Parkin, D Max ^a   Pisani, Paola ^a   Ferlay, J ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER STATISTICS; HUMAN; PRIORITY JOURNAL; RISK;

EID: 0033008968     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.49.1.33     Document Type: Article

References (32)

1. Pisani P, Ferlay J: Prevalence data, in Ferlay J, Black RJ, Pisani P, et al (eds): EUCAN90: Cancer in the European Union. Lyon, France, International Agency for Research on Cancer, 1996, pp 5-6. IARC CancerBase No. 1.
2. Pisani P, Parkin DM, Ferlay J: Estimates of the worldwide mortality from eighteen major cancers in 1985: Implications for prevention, and projections of future burden. Int J Cancer 1993;55:891-903.
3. Parkin DM, Hakulinen T: Analysis of survival, in Jensen OM, Parkin DM, Maclennan R, et al (eds): Cancer Registration, Principles and Methods. Lyon, France, International Agency for Research on Cancer, 1991, pp 159-176. IARC Scientific Publication No. 95
4. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 1998, in press.
5. Ferlay J, Parkin DM, Pisani P: GLOBOCAN: Cancer Incidence and Mortality Worldwide. Lyon, France, International Agency for Research on Cancer, 1998. IARC CancerBase No. 3.
6. World Health Statistics Annual. Geneva, Switzerland, World Health Organization, 1993.
7. Sankaranarayanan R, Black RJ, Parkin DM (eds): Cancer Survival in Developing Countries. Lyon, France, International Agency for Research on Cancer, 1998, in press. IARC Scientific Publication No. 145.
8. Gloeckler-Ries LA, Kosary CL, Hankey BF, et al (eds): SEER Cancer Statistics Review 1973-1994. Bethesda, MD, US Dept of Health and Human Services, National Cancer Institute, 1997. NIH Publication No. 97-2789.
9. Berrino F, Sant M, Verdecchia A, et al (eds): Survival of Cancer Patients in Europe: The EUROCARE Study. Lyon, France, International Agency for Research on Cancer, 1995. IARC Scientific Publication No. 132.
10. Doll R, Peto R: The Causes of Cancer. Oxford, Oxford University Press, 1981.
11. Parkin DM, Pisani P, Lopez AD, et al: At least one in seven cases of cancer is caused by smoking: Global estimates for 1985. Int J Cancer 1994;59: 494-504.
12. IARC Monograph on the Evaluation of Carcinogenic Risks to Humans, Vol. 61. Schistosomes, Liver Flukes and Helicobacter pylori. Lyon, France, International Agency for Research on Cancer, 1994.
13. Eurogast Study Group: An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359-1362.
14. Parkin DM, Pisani P, Munoz N, et al: The global health burden of infection associated cancers. Cancer Surv, 1998, in press.
15. Banatvala N, Mayo K, Megraud F, et al: The cohort effect and Helicobacter pylori. J Infect Dis 1993;168,219-221.
16. Ziegler RG, Hoover RN, Pike MC, et al: Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993;85:1819-1827.
17. Kelsey JL, Gammon MD: Epidemiology of breast cancer. Epidemiol Rev 1990;12:228-240.
18. Haenszel W, Kurihara M: Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968;40:43-68.
19. McMichael AJ, McCall MG, Hartshorne JM, et al: Patterns of gastro-intestinal cancer in European migrants to Australia: The role of dietary change. Int J Cancer 1980;25:431-437.
20. Donato F, Boffetta P, Puoti MA: A meta-analysis of ecpidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998;75:347-354.
21. Tanaka H, Hiyama T, Tsukuma H, et al: Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan. Cancer Causes Control 1994;5:409-413.
22. Chang MH, Chen CJ, Lai MS, et al: Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children: Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-1859.
23. Saxen EA: Trends: Facts or fallacy? in Magnus K (ed): Trends in Cancer Incidence: Causes and Practical Implications. Washington DC, Hemisphere, 1982, pp 5-16.
24. Shimizu H, Ross RK, Bernstein L: Possible underestimation of the incidence rate of prostate cancer in Japan. Jpn J Cancer Res 1991;82:483-485.
25. Yatani R, Chigusa I, Akazaki K, et al: Geographic pathology of latent prostatic carcinoma. Int J Cancer 1982;29:611-616.
26. Shibata A, Whittemore A: Genetic predisposition to prostate cancer: Possible explanations for . ethnic differences in risk. Prostate 1997;32:65-72.
27. Brawley OW: Prostate carcinoma incidence and patient mortality: The effects of screening and early detection. Cancer 1997;80:1857-1863.
28. Threlfall TJ, English DR, Rouse IL: Prostate cancer in Western Australia: Trends in incidence and mortality from 1985 to 1996. Med J Aust 1998;169:21-24.
29. IARC Monographs on the Evaluation of Carcinogenic Risks Io Humans, Vol. 64. Human Papillomavirus. Lyon, France, International Agency for Research on Cancer, 1995.
30. Muñoz N, Day N: Esophageal cancer; in Schottenfeld D, Fraumeni JF (eds): Cancer Epidemiology and Prevention, ed 2. New York, Oxford University Press, 1996.
31. Hankey BF, Edwards BK, Ries LA, et al: Problems in cancer surveillance: Delineating in situ and invasive bladder cancer. J Natl Cancer Inst 1991;83:384-385. Editorial.
32. Parkin DM, Whelan SL, Ferlay J, et al (eds): Cancer Incidence in Five Continents. Vol VII. Lyon, France, International Agency for Research on Cancer, 1997, pp 1028-1029. IARC Scientific Publication No. 143.